Noha Elemam | Immuno-oncology | Women Researcher Award

Women Researcher Award

Noha Elemam
University of Sharjah, United Arab Emirates
Noha Elemam
Affiliation University of Sharjah
Country United Arab Emirates
Scopus ID 56442766900
Documents 97
Citations 14513
h-index 28
Subject Area Immuno-oncology
Event International Young Scientists Award
ORCID 0000-0002-3586-6731

Noha Elemam is a researcher affiliated with the University of Sharjah, United Arab Emirates, recognized for scholarly contributions in the field of Immuno-oncology. Her research profile demonstrates extensive publication activity, high citation visibility, and measurable scientific impact in cancer immunology and translational biomedical research.[1] The researcher’s work contributes to scientific understanding of immune responses in oncology and the development of therapeutic strategies within modern biomedical sciences.[2]

Abstract

This article presents an academic overview of Noha Elemam and her scholarly contributions in Immuno-oncology. The profile summarizes research productivity, citation performance, publication visibility, and scientific engagement in biomedical and cancer immunology research.[1] The documented research indicators demonstrate substantial academic influence within internationally indexed scientific literature and translational oncology studies.[3]

Keywords

  • Women Researcher Award
  • Immuno-oncology
  • Cancer Immunology
  • Biomedical Research
  • Scientific Publications
  • Translational Medicine
  • Academic Excellence
  • International Young Scientists Award

Introduction

Immuno-oncology is a rapidly developing biomedical discipline focused on understanding the interactions between the immune system and cancer progression. Scientific advances in this area contribute to immunotherapeutic strategies, cancer diagnostics, targeted therapies, and translational clinical applications.[2]

Noha Elemam has contributed to scientific investigations within oncology and immunological sciences through peer-reviewed research publications and internationally indexed scholarly dissemination. Her academic profile reflects significant visibility and measurable impact within biomedical literature databases.[1]

Research Profile

According to indexed scholarly databases, Noha Elemam has authored 97 scientific documents with more than 14,500 citations and an h-index of 28. These metrics demonstrate substantial research dissemination, citation visibility, and influence within biomedical sciences and Immuno-oncology research.[1]

The researcher’s affiliation with the University of Sharjah supports interdisciplinary biomedical research and collaboration in oncology, immunology, and translational medicine. Academic profiles available through ORCID, Google Scholar, and Scopus further enhance international research accessibility.[4]

  • Affiliation: University of Sharjah
  • Country: United Arab Emirates
  • Scopus Indexed Documents: 97
  • Citation Count: 14513
  • h-index: 28
  • Research Area: Immuno-oncology

Research Contributions

Research contributions associated with Noha Elemam involve cancer immunology, immune regulation, translational oncology, and therapeutic mechanisms related to tumor progression and immune system interactions.[2] Such investigations contribute to scientific understanding of immunotherapy pathways and biomolecular mechanisms within oncology research.[5]

The researcher’s publication record demonstrates participation in peer-reviewed biomedical dissemination systems and collaborative scientific investigations involving advanced cancer research methodologies.[3]

  • Cancer immunology and immunotherapy research
  • Translational biomedical investigations
  • Tumor microenvironment studies
  • Immune response and therapeutic mechanism analysis
  • International scientific collaboration and publication dissemination

Publications

The publication portfolio associated with Noha Elemam demonstrates extensive engagement in biomedical and oncology-related research dissemination. Indexed publications contribute to international scientific visibility and support ongoing advancements in translational medicine and cancer immunology.[1]

  1. Research articles involving immunological mechanisms in cancer progression.
  2. Scientific studies related to translational oncology and immunotherapy.
  3. Peer-reviewed publications indexed in international databases.
  4. Collaborative biomedical research dissemination.

Research Impact

The citation profile associated with Noha Elemam indicates substantial scientific influence within Immuno-oncology and biomedical research literature. High citation visibility reflects broad academic engagement and scholarly utilization of the researcher’s scientific contributions.[1]

Research impact within cancer immunology contributes to improved understanding of immune mechanisms, therapeutic innovations, and translational clinical strategies in oncology. Scientific dissemination through internationally indexed journals further supports global academic collaboration and biomedical advancement.[5]

Award Suitability

The academic profile of Noha Elemam demonstrates strong alignment with scientific recognition frameworks emphasizing research productivity, scholarly influence, citation performance, and international publication dissemination.[3]

The Women Researcher Award and International Young Scientists Award recognize researchers demonstrating measurable academic contributions and scientific advancement within specialized research disciplines. Based on indexed publication metrics and research visibility, the profile reflects notable achievement within Immuno-oncology and biomedical sciences.[4]

  • Extensive scholarly publication record
  • High citation visibility and measurable research impact
  • Contribution to Immuno-oncology advancements
  • Participation in international biomedical dissemination systems
  • Alignment with scientific recognition and academic excellence initiatives

Conclusion

Noha Elemam has established a highly visible academic profile in Immuno-oncology through extensive publication activity, significant citation influence, and contributions to biomedical and translational cancer research. Affiliation with the University of Sharjah supports continued engagement in internationally recognized scientific investigations.[1]

The documented scholarly metrics and research contributions demonstrate suitability for academic recognition initiatives such as the Women Researcher Award and the International Young Scientists Award. Continued scientific dissemination and interdisciplinary biomedical collaboration may further strengthen global research impact and innovation within oncology sciences.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Noha Elemam, Author ID 56442766900. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56442766900
  2. Nature Reviews Cancer. (2020). Advances in Immuno-oncology and cancer immunotherapy research.
    https://doi.org/10.1038/s41568-020-0271-3
  3. The Lancet Oncology. (2020). Emerging developments in translational oncology and immunotherapy.
    https://doi.org/10.1016/S1470-2045(20)30577-8
  4. Young Scientist Awards. (n.d.). International Young Scientists Award academic recognition guidelines.
    https://youngscientistawards.com/
  5. Cancer Immunology Research. (2021). Immune mechanisms and therapeutic innovations in oncology sciences.
    https://doi.org/10.1158/2326-6066.CIR-21-0010

Maonan Wang | Tumor metabolism | Best Researcher Award

Dr. Maonan Wang | Tumor metabolism | Best Researcher Award

Assistant Professor | Central south university, China

Maonan Wang is an Assistant Professor at the Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, China. He holds a Ph.D. from Southeast University and completed a Joint-Ph.D. at the National University of Singapore. His research focuses on nanomedicine, tumor immunotherapy, and biomaterials for cancer treatment. Wang has published extensively in high-impact journals, contributing to advances in cancer diagnostics and therapeutics. His work involves innovative nano-delivery systems and biosynthesized nanomaterials. He has received multiple research accolades and actively collaborates on interdisciplinary biomedical projects.

Profile

Scopus

🎓 Education

Ph.D., Southeast University (2018-2022). Joint-Ph.D., National University of Singapore, Chemical and Biomolecular Engineering (2021-2022). M.D., Central South University (2015-2018). B.D., Changzhi Medical College (2011-2015). Currently serving as an Assistant Professor at Central South University since August 2022.

💼 Experience

Assistant Professor, Central South University (2022-Present). Researcher, National University of Singapore (2021-2022). Ph.D. Researcher, Southeast University (2018-2022). Extensive experience in nanomedicine, cancer therapy, and biomaterials research. Collaborated on multiple interdisciplinary projects in pathology and biomedical engineering

🏆 Awards & Honors

Published in top journals like PNAS, Bioactive Materials, Nano Today, Coordination Chemistry Reviews. Recognized for groundbreaking work in nano-delivery systems and cancer therapeutics. Received multiple research grants and fellowships for contributions to biomedicine. Acknowledged for excellence in interdisciplinary biomedical research and innovation

🔬 Research Focus

Nanomedicine and cancer immunotherapy. Tumor-targeted drug delivery and nano-biomaterials. Biosynthesized nanoparticles for therapeutic applications. Photothermal PCR and rapid nucleic acid detection. Exploring tumor microenvironment and immune evasion mechanisms

🔹 Conclusion

Maonan Wang is a strong candidate for the Best Researcher Award, given his high-impact publications, interdisciplinary expertise, and contributions to biomedical nanotechnology and cancer therapy. Strengthening his profile with grants, mentorship roles, and translational research impact could further bolster his competitiveness. 🚀

Publication

  • Title: In situ self-assembling Au-DNA complexes for targeted cancer bioimaging and inhibition
    Year: 2020
    Author: Maonan Wang, Yun Chen, Weijuan Cai, Huan Feng, Tianyu Du, Weiwei Liu, Hui Jiang, Alberto Pasquarelli, Yossi Weizmann*, Xuemei Wang*
    Citation: PNAS, 117: 308 (IF=11.1)

 

  • Title: Baiting bacteria with amino acidic and peptidic corona coated defect-engineered antimicrobial nanoclusters for optimized wound healing
    Year: 2024
    Author: Maonan Wang†, Houjuan Zhu†, Yuling Xue, Yanxia Duan, Hua Tian, Qi Liu, Yuzhu Zhang, Zibiao Li, Xian Jun Loh, Enyi Ye, Gang Yin, Xuemei Wang, Xianguang Ding, David Tai Leong*
    Citation: Bioactive Materials, 42: 628-643 (IF=18)

 

  • Title: An ultrafast and portable nucleic acid detection system based on photothermal PCR and real-time fluorescence detection
    Year: 2023
    Author: Liangxi Zhu, Jingzhou Zhao, Yile Fang, Zhukang Guo, Maonan Wang*, Nongyue He*
    Citation: Nano Today, 53: 102019 (IF=13.2)

 

  • Title: Advance of nano anticancer therapies targeted on tumor-associated macrophages
    Year: 2021
    Author: Maonan Wang, Jingzhou Zhao, Hongjie Xiong, Hongbing Lu, Hui Jiang, Xuemei Wang*
    Citation: Coordination Chemistry Reviews, 446: 214126 (IF=20.6)

 

  • Title: Tumor targeted nano-delivery system of therapeutic RNA
    Year: 2022
    Author: Maonan Wang, Jingzhou Zhao, Hui Jiang, Xuemei Wang*
    Citation: Materials Horizons, 9: 1111-1140 (IF=13.3)

 

  • Title: Bio-assembled smart nanocapsules for targeted delivery of KRAS shRNA and cancer cell bioimage
    Year: 2023
    Author: Maonan Wang, Zengchao Guo, Jiayu Zeng, Liu Liu, Yihan Wang, Jinpeng Wang, Hongbing Lu, Haijun Zhang, Hui Jiang, Xuemei Wang*
    Citation: Chinese Chemical Letters, 34: 107651 (IF=9.1)

 

  • Title: In situ biosynthesized gold nanoclusters inhibiting cancer development via the PI3K–AKT signaling Pathway
    Year: 2019
    Author: Maonan Wang†, Zeqian Yu†, Huan Feng, Jianling Wang, Lishan Wang, Yu Zhang, Lihong Yin, Ying Du, Hui Jiang, Xuemei Wang*, Jiahua Zhou*
    Citation: Journal of Materials Chemistry B, 7(35): 5336-5344 (IF=7.57)

 

  • Title: Biophysics involved in the process of tumor immune escape
    Year: 2022
    Author: Maonan Wang, Hui Jiang, Xiaohui Liu*, Xuemei Wang*
    Citation: iScience, 25: 104124 (IF=5.8)

 

  • Title: The long noncoding RNA AATBC promotes breast cancer migration and invasion by interacting with YBX1 and activating the YAP1/Hippo signaling pathway
    Year: 2021
    Author: Maonan Wang†, Manli Dai†, Dan Wang†, Ting Tang, Fang Xiong, Bo Xiang, Ming Zhou, Xiaoling Li, Yong Li, Wei Xiong, Guiyuan Li, Zhaoyang Zeng*, Can Guo*
    Citation: Cancer Letters, 512: 60-72 (IF=9.7)

 

  • Title: The regulatory networks of the Hippo signaling pathway
    Year: 2021
    Author: Maonan Wang, Manli Dai, Dan Wang, Wei Xiong, Zhaoyang Zeng*, Can Guo*
    Citation: Journal of Cancer, 12(20): 6216-6230 (IF=3.9)

 

  • Title: Additive Manufacturing in Orthopedics: A Review
    Year: 2022
    Author: Yingchao Zhao, Zhen Wang, Jingzhou Zhao, Mubashir Hussain, Maonan Wang*
    Citation: ACS Biomaterials Science & Engineering, 8(4): 1367-1380 (IF=5.7)